We are live on ! Find out more
CTMX icon

CytomX Therapeutics
CTMX

119 hedge funds and large institutions have $299M invested in CytomX Therapeutics in 2019 Q4 according to their latest regulatory filings, with 23 funds opening new positions, 44 increasing their positions, 35 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

35% more first-time investments, than exits

New positions opened: 23 | Existing positions closed: 17

26% more repeat investments, than reductions

Existing positions increased: 44 | Existing positions reduced: 35

13% more capital invested

Capital invested by funds: $264M → $299M (+$34.7M)

5% more funds holding

Funds holding: 113 → 119 (+6)

0.33% more ownership

Funds ownership: 78.92% → 79.25% (+0.33%)

Holders
119
Holders Change
+6
Holders Change %
+5.31%
% of All Funds
2.34%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
23
Increased
44
Reduced
35
Closed
17
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
First Manhattan
First Manhattan
New York
+$6.6M
2
Point72 Asset Management
Point72 Asset Management
Connecticut
+$4.86M
3
Renaissance Technologies
Renaissance Technologies
New York
+$3.58M
4
PAM
Panagora Asset Management
Massachusetts
+$3.26M
5
EC
EcoR1 Capital
California
+$2.77M

Top Sellers

Rank Fund Capital Flow
1
Wellington Management Group
Wellington Management Group
Massachusetts
-$27.5M
2
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$10.2M
3
BI
BVF Inc
California
-$7.5M
4
State Street
State Street
Massachusetts
-$3.72M
5
SIM
Spark Investment Management
New York
-$901K
Name Holding Trade Value Shares
Change 		Change in
Stake
PP
51
PDT Partners
New York
$816K +$54.8K +8,120 +9%
CPC
52
Congress Park Capital
New York
$787K -$494K -73,150 -44%
AA
53
ALPS Advisors
Colorado
$766K +$622K +92,233 New
California Public Employees Retirement System
54
California Public Employees Retirement System
California
$744K +$122K +18,100 +25%
EAM
55
Exane Asset Management
France
$730K +$228K +33,811 +63%
Swiss National Bank
56
Swiss National Bank
Switzerland
$722K +$20.2K +3,000 +4%
WCM
57
Weld Capital Management
New York
$702K -$12.9K -1,918 -2%
HP
58
Harbourvest Partners
Massachusetts
$658K – – –
Tudor Investment Corp
59
Tudor Investment Corp
Connecticut
$655K +$532K +78,779 New
Walleye Capital
60
Walleye Capital
New York
$585K +$475K +70,397 New
California State Teachers Retirement System (CalSTRS)
61
California State Teachers Retirement System (CalSTRS)
California
$583K – – –
KCM
62
Kennedy Capital Management
Missouri
$580K -$4.52K -670 -1%
State of Wisconsin Investment Board
63
State of Wisconsin Investment Board
Wisconsin
$561K – – –
Morgan Stanley
64
Morgan Stanley
New York
$557K +$282K +41,846 +166%
RhumbLine Advisers
65
RhumbLine Advisers
Massachusetts
$518K +$7.74K +1,147 +2%
AllianceBernstein
66
AllianceBernstein
Tennessee
$489K -$593K -87,837 -60%
VEA
67
Virtus ETF Advisers
New York
$478K +$224K +33,236 +137%
UBS Group
68
UBS Group
Switzerland
$475K -$216K -32,032 -36%
Barclays
69
Barclays
United Kingdom
$452K +$187K +27,774 +105%
SO
70
STRS Ohio
Ohio
$427K -$56.7K -8,400 -14%
Lazard Asset Management
71
Lazard Asset Management
New York
$412K -$10.8K -1,600 -3%
New York State Common Retirement Fund
72
New York State Common Retirement Fund
New York
$411K -$9.45K -1,400 -3%
American Century Companies
73
American Century Companies
Missouri
$363K -$533K -78,930 -64%
Russell Investments Group
74
Russell Investments Group
United Kingdom
$363K +$296K +43,894 New
Allianz Asset Management
75
Allianz Asset Management
Germany
$321K -$702K -103,991 -73%
1 2
3
4 5

CTMX Hedge Fund Activity: Q4 2019 in Review

119 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in CytomX Therapeutics (CTMX) for Q4 2019, worth a combined $299M — up 13% from $264M a quarter earlier.

Buyers outnumbered sellers: 23 funds opened new CTMX positions and 17 closed out — a net gain of 6 holders — while 44 added to existing stakes and 35 trimmed.

The largest buyer was First Manhattan, opening a new position worth an estimated $6.6M. The largest seller was Wellington Management Group, cutting an estimated $27.5M.

  • 119 institutional investors held CytomX Therapeutics (CTMX) as of Q4 2019, up from 113 in Q3 2019.
  • Funds reported $299M of CytomX Therapeutics stock for Q4 2019, up 13% quarter-over-quarter.
  • 23 funds opened new CytomX Therapeutics positions in Q4 2019 and 17 closed out, a net change of +6 holders.
  • The largest CytomX Therapeutics buyer in Q4 2019 was First Manhattan, an estimated $6.6M added.
  • The largest CytomX Therapeutics seller in Q4 2019 was Wellington Management Group, an estimated $27.5M sold.

Based on aggregated 13F filings for Q4 2019.